ARTICLES BY THIS AUTHOR
- 9/5/2011
Apixaban may be a safer anti-platelet therapy than existing options
The investigative oral Factor Xa inhibitor apixaban could prevent strokes among atrial fibrillation patients better than current treatments—and may be able to perform that task without a risk of excessive bleeding. - 9/5/2011
Rate of hip fractures in over-60s is decreasing
But study conducted in British Columbia shows actual numbers are still rising - 9/5/2011
Adding rituximab to other biologics may be safe in rheumatoid arthritis
In an open-label study to investigate the safety of combining biologic agents in the treatment of rheumatoid arthritis, researchers found little serious risk when rituximab (Rituxan) was added to other drugs. - 9/5/2011
Knee replacement ORs are a wasteland
Audit shows procedure results in a lot of waste; Ontario hospital puts greater effort into recycling as a result - 9/5/2011
Remicade: now approved for ulcerative colitis in children
First biologic agent approved for the treatment of moderately to severely active ulcerative colitis in children.